Effect of folic acid on bone metabolism: A randomized double blind clinical trial in postmenopausal osteoporotic women

DARU, Journal of Pharmaceutical Sciences

Volumn 22, Issue 1, 2014, Pages

  Salari, Pooneh ^a   Abdollahi, Mohammad ^b   Heshmat, Ramin ^c   Aghaei Meybodi, Hamidreza ^c   Razi, Farideh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BMD; Bone biomarkers; Clinical trial; Folic acid; Homocysteine; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; OSTEOCALCIN; PLACEBO; VITAMIN B COMPLEX;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; BONE; DIETARY SUPPLEMENT; METABOLISM; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; URINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; BONE AND BONES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; VITAMIN B COMPLEX;

EID: 84908211697     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/s40199-014-0062-9     Document Type: Article

References (40)

1. Salari P, Abdollahi M: A comprehensive review of the shared roles of inflammatory cytokines in osteoporosis and cardiovascular diseases as two common old people problem: actions toward development of new drugs. Int J Pharmacol 2011, 7(5):552-567.
2. Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 2002, 325:1202-1206.
3. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002, 346:476-483.
4. Salari P, Abdollahi M: Association of hyperhomocysteinemia with osteoporosis: a systematic review. Therapy 2008, 5(2):215-222.
5. Salari P, Abdollahi M: The role of platelets in bone remodeling. Inflamm Allergy Drug Target 2010, 9:393-399.
6. Salari P, Abdollahi M: Controversial effects of non-steroidal anti-inflammatory drugs on bone: a review. Inflamm Allergy Drug Target 2009, 8:169-175.
7. Salari Sharif P, Asalforoush M, Ameri F, Larijani B, Abdollahi M: The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. AGE 2010, 32:179-186.
8. Salari Sharif P, Abdollahi M: A systematic review on the relation between use of statins and osteoporosis. Int J Pharmacol 2011, 7(2):180-188.
9. Salari Sharif P, Abdollahi M: A systematic review on the relationship between β-blockers and bone health. Int J Pharmacol 2010, 6(5):577-583.
10. Abdollahi M, Larijani B, Rahimi R, Salari P: Role of oxidative stress in osteoporosis. Therapy 2005, 2(5):787-796.
11. Brattstrom L: Vitamins as homocysteine-lowering agents. J Nutr 1996, 126:S1276-S1280.
12. LeBoff MS, Narweker R, LaCroix A, Wu L, Jackson R, Lee J, Bauer DC, Cauley J, Kooperberg C, Lewis C, Thomas AM, Cummings S: Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab 2009, 94:1207-1213.
13. Leeming DJ, Alexandersen P, Karsdal MA, Qvist P, Schaller S, Tankó LB: An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol 2006, 62:781-792.
14. Homocysteine Lowering Trialists Collaboration: Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ 1998, 316:894-898.
15. Van Wijngaarden JP, Dhonukshe-Rutten RA, Van Schoor NM, van der Velde N, Swart KM, Enneman AW, Van Dijk SC, Brouwer-Brolsma EM, Zilikens MC, Van Meurs JB, Brug J, Uitterlinden AG, Lips P, De Groot LC: Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence. BMC Geriatric 2011, 11:80.
16. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N: A reference standard for the description of osteoporosis. Bone 2008, 42:467-475.
17. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999, 340:1449-1454.
18. Keser I, Ilich JZ, Vrkic N, Giljevic Z, Colic Baric I: Folic acid and vitamin B12 supplementation lowers plasma homocysteine but has no effect on serum bone turnover markers in elderly women: a randomized, double-blind, placebo-controlled trial. Nutr Res 2013, 33:211-219.
19. Wolters M, Hermann S, Hahn A: Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years. Eur J Nutr 2005, 44:183-192.
20. Lewerin C, Nilsson-Ehle H, Matousek M, Lindstedi G, Steen B: Reduction of plasma homocysteine and serum methylmalonate concenttrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomized trial. Eur J Clin Nutr 2003, 57: 1426-1436.
21. Anderson CAM, Jee SH, Charleston J, Narrett M, Appel LJ: Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial. Am J Epidemiol 2010, 172:932-941.
22. Van der Driend R, Biesma DH, Banga JD: Postmethionine-load homocysteine determination for the diagnosis of hyperhomocysteinemia and efficacy of homocysteine lowering treatment regimens. Vasc Med 2001, 7:29-33.
23. Bozkurt N, Erdem M, Yilmaz E, Erdem A, Biri A, Kubatova A, Bozkurt M: The relationship of homocysteine B12 and folic acid with the bone mineral density of the femur and lumbar spine in Turkish postmenopausal women. Arch Gynecol Obstet 2009, 280:381-387.
24. Bucciarelli P, Martini G, Martinelli I, Ceccarelli E, Gennari L: The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women. European J Intern Med 2010, 21:301-305.
25. Kuyumcu ME, Yesil Y, Oztürk ZA, Cinar E, Kizilarslanoglu C, Halil M, Ulger Z, Yesil NK, Cankurtaran M, Anogul S: The association between homocysteine (hcy) and serum natural antioxidants in elderly bone mineral densitometry (BMD). Arch Gerontol Geriatr 2012, 55:739-743.
26. Van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, De Jonge R, Lindemans J, De Groot LC, Hofman A, Witteman JC, Van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG: Homocysteine levels and the risk of osteoporotic fracture. N Eng J Med 2004, 350: 2033-2041.
27. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP: Homocysteine as a predictive factor for hip fracture in older persons. N Eng J Med 2004, 350:2042-2049.
28. Holstein JH, Herrmann M, Splett C, Hermann W, Garcia P, Histing T, Klein M, Kurz K, Siebel T, Pohlemann T, Menger MD: Hyper homocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis. Clin Chem Lab Med 2010, 48:821-827.
29. Rumbak I, Zizic V, Sokolić L, Cvijetićc S, Kajfež R, Barić IC: Bone mineral density is not associated with homocysteine level, folate and vitamin B12 status. Arch Gyneol Obstet 2012, 285:991-1000.
30. Kim BJ, Koh JM, Ahn SH, Lee SH, Kim EH, Bae SJ, Kim HK, Choe JW, Lim KH, Pyun KH, Kim TH, Kim SY, Kim GS: High serum total homocysteine levels accelerates hip bone loss in healthy premenopausal women and men. Bone 2013, 52:56-62.
31. Maghraoui AE, Ghozlani I, Mounach A, Rezqi A, Oumghar K, Achemlal L, Bezza A, Ouzzif Z: Homocysteine folate and vitamin B12 levels and vertebral fracture risk in postmenopausal women. J Clin Densitometr 2012, 15:328-333.
32. Zhu K, Beilby J, Dick IM, Devine A, Soós M: The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women. Osteoporos Int 2009, 20:1183-1191.
33. Kim GS, Kim CH, Park JY, Lee KU, Park CS: Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism 1996, 45:1443-1446.
34. Herrmann M, Schmist J, Umanskaya N, Colaianni G, Al Marrawi F, Widmann T, Zallone A, Wildemann B, Herrmann W: Stimulation of osteoclast activity by low B-vitamin concentrations. Bone 2007, 41:584-591.
35. Tucker KL, Hannan MT, Qiao N, Jacques PF, Selhub J, Cupples LA, Kiel DP: Low plasma vitamin B12 associated with lower bone mineral density: the Framingham osteoporosis study. J Bone Miner Res 2005, 20: 152-158.
36. Shahab-Ferdows S, Anaya-Loyola MA, Vergara-Castaňeda H, Rosado JL, Keyes WR, Newman JW, Miller JW, Allen LH: Vitamin B-12 supplementation of rural Mexican women changes biochemical vitamin B-12 status indicators but does not affect hematology or a bone turnover marker. J Nutr 2012, 142:1881-1887.
37. Haliloglu B, Aksungar FB, Ilter E, Peker H, Akm FT, Ozekier U: Relationship between bone mineral density bone turnover markers and homocysteine folate and vitamin B12 levels in postmenopausal women. Arch Gynecol Obstet 2010, 281:663-668.
38. Liu G, Nellaiappan K, Kagan HM: Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J Biol Chem 1997, 272:32370-32377.
39. Herrmann M, Umanskaya N, Traber L, Schmidt-Gayk H, Menke W, Lanzer G, Lenhart M, Peter Schmidt J, Herrmann W: The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial. Clin Chem Lab Med 2007, 45:1785-1792.
40. Gerdhem P, Iwaska KK, Isakkson A, Pettersson K, Väänänen HK, Obrant KJ, Akesson K: Associations between homocysteine bone turnover BMD mortality and fracture risk in elderly women. J Bone Miner Res 2007, 22:127-134.